{"id":514,"date":"2021-01-21T20:08:00","date_gmt":"2021-01-21T11:08:00","guid":{"rendered":"https:\/\/idsc-gunma.jp\/congress\/jstm\/?p=514"},"modified":"2022-05-26T20:11:48","modified_gmt":"2022-05-26T11:11:48","slug":"%e8%bf%91%e8%b5%a4%e5%a4%96%e7%b7%9aii%e3%82%92%e7%94%a8%e3%81%84%e3%81%9f%e5%85%89%e6%b8%a9%e7%86%b1%e3%83%95%e3%82%a7%e3%83%ad%e3%83%86%e3%83%a9%e3%83%94%e3%83%bc%e3%81%ae%e3%81%9f%e3%82%81%e3%81%ae","status":"publish","type":"post","link":"https:\/\/idsc-gunma.jp\/congress\/jstm\/%e8%bf%91%e8%b5%a4%e5%a4%96%e7%b7%9aii%e3%82%92%e7%94%a8%e3%81%84%e3%81%9f%e5%85%89%e6%b8%a9%e7%86%b1%e3%83%95%e3%82%a7%e3%83%ad%e3%83%86%e3%83%a9%e3%83%94%e3%83%bc%e3%81%ae%e3%81%9f%e3%82%81%e3%81%ae\/","title":{"rendered":"\u8fd1\u8d64\u5916\u7ddaII\u3092\u7528\u3044\u305f\u5149\u6e29\u71b1\u30d5\u30a7\u30ed\u30c6\u30e9\u30d4\u30fc\u306e\u305f\u3081\u306e\u53ef\u5909\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u534a\u96fb\u5c0e\u6027\u30dd\u30ea\u30de\u30fc\u30ca\u30ce\u30b6\u30a4\u30e0"},"content":{"rendered":"\n<p>\u4e00\u793e\uff09\u65e5\u672c\u30cf\u30a4\u30d1\u30fc\u30b5\u30fc\u30df\u30a2\u5b66\u4f1a\u30cb\u30e5\u30fc\u30b9No.128\u3010\u5b66\u8853\u5831\u544a56\u3011<\/p>\n\n\n\n<p>\u6700\u8fd1\u306e\u8a71\u984c56<\/p>\n\n\n\n<p>\u8fd1\u8d64\u5916\u7ddaII\u3092\u7528\u3044\u305f\u5149\u6e29\u71b1\u30d5\u30a7\u30ed\u30c6\u30e9\u30d4\u30fc\u306e\u305f\u3081\u306e\u53ef\u5909\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u534a\u96fb\u5c0e\u6027\u30dd\u30ea\u30de\u30fc\u30ca\u30ce\u30b6\u30a4\u30e0<\/p>\n\n\n\n<p>\u8fd1\u85e4\u3000\u9686\uff08\u5bcc\u5c71\u5927\u5b66\uff09<\/p>\n\n\n\n<p>\u5149\u6e29\u71b1\u7642\u6cd5(Photothermal therapy, PTT) \u306f\u30ca\u30ce\u7c92\u5b50\u7b49\u3092\u6295\u4e0e\u3057\u3066\u816b\u760d\u306b\u96c6\u7a4d\u3055\u305b\uff0c\u4f53\u5916\u3088\u308a\u8fd1\u8d64\u5916\u7dda\u30ec\u30fc\u30b6\u3092\u7167\u5c04\u3057\uff0c\u71b1\u3092\u653e\u51fa\u3055\u305b\u3066\u304c\u3093\u7d30\u80de\u3092\u6b7b\u6ec5\u3055\u305b\u308b\u4f4e\u4fb5\u8972\u3067\u52b9\u7387\u7684\u306a\u304c\u3093\u306e\u6cbb\u7642\u6cd5\u3068\u3057\u3066\u6ce8\u76ee\u3055\u308c\u3066\u3044\u308b\uff0e\u305d\u306e\u6cbb\u7642\u6280\u8853\u306e\u9ad8\u5ea6\u5316\u304c\u9032\u3093\u3067\u3044\u308b\uff0e\u3053\u3053\u3067\u7d39\u4ecb\u3059\u308b\u7814\u7a76\u5831\u544a\u4f8b<sup>1)<\/sup>\u3067\u306f\u4ee5\u4e0b\uff0c4\u70b9\u306e\u7279\u9577\u3092\u6709\u3059\u308b\uff0e\u2460PTT\u306b\u3088\u308a\u6df1\u9054\u6027\u306e\u9ad8\u3044\u9577\u6ce2\u9577\u8fd1\u8d64\u5916\u7dda(NIR II [1100\uff5e1350 nm \u306e\u6ce2\u9577\u57df])\u3092\u5229\u7528\u3059\u308b\uff0e\u2461\u304c\u3093\u7d30\u80de\u6b7b\u306e\u6a19\u7684\u3092\u30d5\u30a7\u30ed\u30c8\u30fc\u30b7\u30b9(Ferroptosis)\u3068\u3059\u308b\uff0e\u2462\u65b0\u898f\u304c\u3093\u6cbb\u7642\u306e\u30d5\u30a7\u30ed\u30c6\u30e9\u30d4\u30fc\uff08Ferrotherapy\uff09\u306e\u6cbb\u7642\u52b9\u679c\u6539\u5584\u3092\u76ee\u6307\u3057\u3066PTT\u3068\u4f75\u7528\u3059\u308b\uff0e\u2463\u5149\u97f3\u97ff\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0*\u5206\u5b50\u3092\u642d\u8f09\u3057\u305f\u6cbb\u7642\u7528\u30ca\u30ce\u30b6\u30a4\u30e0(\u9175\u7d20\u69d8\u6027\u8cea\u3092\u6709\u3059\u308b\u30ca\u30ce\u6750\u6599)\u3092\u4f5c\u88fd\u3057\u5229\u7528\u3059\u308b\uff0e<\/p>\n\n\n\n<p>\u30d5\u30a7\u30ed\u30c8\u30fc\u30b7\u30b9\u3068\u306f2012\u5e74\u306b\u30b3\u30ed\u30f3\u30d3\u30a2\u5927\u5b66\u306eStockwell\u3089\u306e\u30b0\u30eb\u30fc\u30d7\u304c\u5831\u544a\u3057\u305f\uff0c\u9244\u30a4\u30aa\u30f3\u4f9d\u5b58\u7684\u306a\u5236\u5fa1\u3055\u308c\u305f\u7d30\u80de\u6b7b\u306e\u4e00\u7a2e\u3067\u3042\u308b<sup>2)<\/sup>\uff0e\u5f7c\u3089\u306fRas\u5909\u7570\u304c\u3093\u7d30\u80de\u306b\u7279\u7570\u7684\u306b24\u6642\u9593\u4ee5\u5185\u306b\u7d30\u80de\u6b7b\u3092\u8a98\u5c0e\u3059\u308b\u5316\u5408\u7269Erastin*\u3084RSL3*\u898b\u51fa\u3057\uff0c\u3053\u306e\u7d30\u80de\u6b7b\u304c\u9244\u30ad\u30ec\u2212\u30bf\u30fc\u3084\u6297\u9178\u5316\u5264\u3067\u3042\u308bFerrostatin-1 *\u3067\u6291\u5236\u3055\u308c\u308b\u3053\u3068\u304b\u3089\u30d5\u30a7\u30ed\u30c8\u30fc\u30b7\u30b9\u3068\u540d\u4ed8\u3051\u305f\uff0eErastin\u306f\u30b7\u30b9\u30c1\u30f3\u30c8\u30e9\u30f3\u30b9\u30dd\u30fc\u30bf\u30fc\u3092\u6291\u5236\u3059\u308b\u3053\u3068\u3067\u7d30\u80de\u5185\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u3092\u6e1b\u5c11\u3055\u305b\uff0c\u307e\u305fRSL3\u306f\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u30da\u30eb\u30aa\u30ad\u30b7\u30c0\u30fc\u30bc4 (GPx4)\u306b\u76f4\u63a5\u7d50\u5408\u3059\u308b\u3053\u3068\u306b\u3088\u308a\uff0c\u3069\u3061\u3089\u3082GPx4\u6d3b\u6027\u3092\u6291\u5236\u3059\u308b\u3053\u3068\u306b\u3088\u3063\u3066\u8102\u8cea\u9178\u5316\u4f9d\u5b58\u7684\u306a\u7d30\u80de\u6b7b\u3092\u8a98\u5c0e\u3059\u308b\uff0e\u30a2\u30dd\u30c8\u30fc\u30b7\u30b9\uff0c\u30cd\u30af\u30ed\u30fc\u30b7\u30b9\u304a\u3088\u3073\u30aa\u30fc\u30c8\u30d5\u30a1\u30b8\u30fc\u7b49\u65e2\u77e5\u306e\u7d30\u80de\u6b7b\u3068\u306e\u5171\u901a\u70b9\u3082\u5c11\u306a\u304f\uff0c\u751f\u5316\u5b66\u7684\u904e\u7a0b\u3082\u7570\u306a\u308b\uff0e\u30d5\u30a7\u30ed\u30c8\u30fc\u30b7\u30b9\u306f\u7d30\u80de\u5185\u904a\u96e2\u9244\u306b\u4f9d\u5b58\u3057\u305f\u6d3b\u6027\u9178\u7d20\u7a2e\u306e\u767a\u751f\u3068\u8102\u8cea\u904e\u9178\u5316\u306e\u84c4\u7a4d\u306b\u4f9d\u5b58\u3059\u308b\uff0e<\/p>\n\n\n\n<p>\u30d5\u30a7\u30ed\u30bb\u30e9\u30d4\u30fc\u306f\u9244\u30a4\u30aa\u30f3\u3092\u5229\u7528\u3057\u3066H<sub>2<\/sub>O<sub>2<\/sub>\u304b\u3089\u3088\u308a\u7d30\u80de\u6bd2\u6027\u306e\u9ad8\u3044\u30cf\u30a4\u30c9\u30ed\u30ad\u30b7\u30e9\u30b8\u30ab\u30eb\uff08\u00b7OH\uff09\u306e\u767a\u751f\u3092\u8a98\u5c0e\u3057\uff0c\u304c\u3093\u7d30\u80de\u306b\u30d5\u30a7\u30ed\u30c8\u30fc\u30b7\u30b9\u3092\u8a98\u767a\u3057\uff0c\u304c\u3093\u6cbb\u7642\u3092\u76ee\u6307\u3059\u624b\u6cd5\u3067\u3042\u308b<sup>3)<\/sup>\uff0e\u3057\u304b\u3057\uff0c\u816b\u760d\u74b0\u5883\u3067\u306f\u30d5\u30a7\u30f3\u30c8\u30f3\u53cd\u5fdc\u306e\u89e6\u5a92\u52b9\u7387\u304c\u4f4e\u3044\u305f\u3081\u6cbb\u7642\u52b9\u679c\u306f\u4f4e\u3044\uff0e\u305d\u306e\u305f\u3081\uff0c\u4eca\u56de\u7d39\u4ecb\u3059\u308b\u8ad6\u6587<sup>1)<\/sup>\u3067\u306f\u30d5\u30a7\u30ed\u30c8\u30fc\u30b7\u30b9\u8a98\u5c0e\u7528\u306e\u30ca\u30ce\u30b6\u30a4\u30e0\u3092\u7528\u3044\uff0cNIR II\u3092\u7528\u3044\u3066\u6cbb\u7642\u52b9\u679c\u306e\u5411\u4e0a\u3092\u691c\u8a0e\u3057\u305f\uff0e<\/p>\n\n\n\n<p>\u30ca\u30ce\u30b6\u30a4\u30e0\u306b\u306f\u5f37\u529b\u306a\u96fb\u5b50\u5438\u5f15\u57fa\u3068\u3057\u3066TDQ*, \u5438\u53ce\u30b9\u30da\u30af\u30c8\u30eb\u306e\u5fae\u8abf\u6574\u5206\u5b50\u3068\u3057\u3066 BDT*, \u307e\u305f CPDT-Br*\u3092\u6dfb\u52a0\u3057\uff0c\u3055\u3089\u306bPEG*\u3092\u4ed8\u52a0\u3057\u3066pTBCB-PEG\u3092\u5408\u6210\uff0c\u3053\u308c\u306b\u7b2c2\u9244\u30a4\u30aa\u30f3\u3092\u52a0\u3048\u3066\uff0c\u53ef\u5909\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u534a\u96fb\u5c0e\u6027\u30dd\u30ea\u30de\u30fc\u30ca\u30ce\u30b6\u30a4\u30e0 (Hybrid semiconducting polymer nanozyme, HSN)\u3092\u4f5c\u88fd\u3057\u305f\uff0e\u3053\u308c\u3068\u7b2c2\u9244\u30a4\u30aa\u30f3\u3092\u542b\u307e\u306a\u3044HSN<sub>0<\/sub>\u306b\u3064\u3044\u3066\uff0c\u30de\u30a6\u30b9\u306b\u79fb\u690d\u3057\u305f4T1\u4e73\u304c\u3093\u306e\u5897\u6b96\u6291\u5236\u52b9\u679c\u304a\u3088\u3073\u80ba\u304a\u3088\u3073\u809d\u81d3\u3078\u306e\u8ee2\u79fb\u963b\u5bb3\u52b9\u679c\u3092\u6bd4\u8f03\u3057\u305f\uff0e1064 nm\u30d1\u30eb\u30b9\u30ec\u30fc\u30b6\u3092\u7528\u3044\u305f\u5149\u97f3\u97ff\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306b\u3088\u308b\u89e3\u6790\u3067\u306f\u6295\u4e0e4\u6642\u9593\u5f8c HSN\u304a\u3088\u3073HSN<sub>0<\/sub>\u6fc3\u5ea6\u304c\u6700\u9ad8\u5024\u3092\u793a\u3057\u305f\uff0e\u5149\u7167\u5c04\u6642\u306e\u816b\u760d\u306e\u8868\u9762\u6e29\u5ea6\u306f1\u5206\u5f8c\u306b45<sup>o<\/sup>C\u306b\u9054\u3057\uff0c6\u5206\u5f8c\u3067\u306f\u5176\u300560.8 \u304a\u3088\u3073 59.5<sup>o<\/sup>C\u3067\u3042\u3063\u305f\uff0eHSN\u3092\u7528\u3044\u305fNIR-II \u5149\u6e29\u71b1\u30d5\u30a7\u30ed\u30bb\u30e9\u30d4\u30fc\u3067\u306f\u816b\u760d\u5897\u6b96\u306f\u6291\u5236\u3055\u308c\uff0c\u80ba\u304a\u3088\u3073\u809d\u81d3\u3078\u306e\u8ee2\u79fb\u963b\u5bb3\u52b9\u679c\u3092\u793a\u3057\u305f\u304c\uff0cHSN<sub>0<\/sub>\u3092\u7528\u3044\u305fNIR-II PTT\u306e\u5834\u5408\uff0c\u816b\u760d\u5897\u6b96\u6291\u5236\u52b9\u679c\u306f\u4e2d\u7b49\u5ea6\u3067\u3042\u308a\uff0c\u8ee2\u79fb\u6291\u5236\u52b9\u679c\u306f\u306a\u304b\u3063\u305f\uff0e\u5149\u6e29\u71b1\u6cbb\u7642\u52b9\u679c\u306b\u95a2\u3059\u308b\u816b\u760d\u5185\u306e\u6df1\u3055\u306e\u5f71\u97ff\u306b\u3064\u3044\u3066\u8102\u8cea\u904e\u9178\u5316\u7b49\u3092\u6307\u6a19\u306b\u7d44\u7e54\u5b66\u7684\u306b\u8abf\u3079\u305f\u3068\u3053\u308d\uff0cHSN\u4f7f\u7528\u6642\u306b\u306f9 mm\u306e\u6df1\u3055\u307e\u3067\u5230\u9054\u3057\u305f\u304c\uff0cHSN<sub>0<\/sub>\u4f7f\u7528\u6642\u3067\u306f6 mm\u307e\u3067\u3067\u3042\u3063\u305f\uff0e\u8fd1\u5e74\u306e\u30ca\u30ce\u7c92\u5b50\u306e\u958b\u767a\u3082\u3042\u308a\uff0cPTT\u306e\u7814\u7a76\u306f\u8457\u3057\u3044\u9032\u6b69\u3092\u793a\u3057\u3066\u304d\u305f\uff08PubMed\u691c\u7d22\u3067\u306f5000\u4ef6\u4ee5\u4e0a\u304c\u30d2\u30c3\u30c8\uff09\uff0e\u4eca\u5f8c\u306f\u81e8\u5e8a\u5fdc\u7528\u306e\u7814\u7a76\u304c\u9032\u3080\u3053\u3068\u304c\u671f\u5f85\u3055\u308c\u308b\uff0e<\/p>\n\n\n\n<p>\u53c2\u8003\u6587\u732e<\/p>\n\n\n\n<p>1) Jiang Y,&nbsp;<em>et al<\/em>. Transformable hybrid semiconducting polymer nanozyme for second near-infrared photothermal ferrotherapy. Nat Commun, 11:1857, 2020.<\/p>\n\n\n\n<p>2) Dixon SJ,&nbsp;<em>et al<\/em>. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 149: 1060-72, 2012.<\/p>\n\n\n\n<p>3) Tarangelo A, Dixon SJ. An iron age for cancer therapy. Nat Nanotechnol, 11: 921\u20132, 2016.<\/p>\n\n\n\n<p>\u7528\u8a9e\u89e3\u8aac<\/p>\n\n\n\n<p>*\u5149\u97f3\u97ff\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\uff08Photoacoustic Imaging: PAI\uff09\uff1a\u5149\u97f3\u97ff\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3068\u306f\uff0c\u5149\u97f3\u97ff\u52b9\u679c\u3092\u5229\u7528\u3057\u305f\u753b\u50cf\u5316\u306e\u624b\u6cd5\uff0ePAI\u306f\u8fd1\u8d64\u5916\u5149\u3092\u4f7f\u3044\uff0c\u97f3\u3067\u6e2c\u5b9a\u3059\u308b\u3053\u3068\u3067\u753b\u50cf\u5316\u3059\u308b\u305f\u3081\uff0c\u8d85\u97f3\u6ce2\u3068\u86cd\u5149\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0(FI)\u306e\u624b\u6cd5\u3092\u517c\u306d\u5099\u3048\u3066\u3044\u308b\uff0eFI\u306e\u6df1\u5ea6\u306f5 mm\u672a\u6e80\u3067\u3042\u308a\uff0c\u76ae\u819a\u8fd1\u508d\u3084\u53d6\u308a\u51fa\u3057\u305f\u90e8\u4f4d\u306b\u6e2c\u5b9a\u5bfe\u8c61\u304c\u9650\u3089\u308c\u308b\uff0e\u4e00\u65b9 PAI\u3067\u306e\u6df1\u5ea6\u306f5 cm\u3067\u3042\u308b\uff0e\u3055\u3089\u306b\u86cd\u5149\u5206\u5b50\u3092\u30b3\u30f3\u30c8\u30e9\u30b9\u30c8\u5264\u3068\u3057\u3066\u7528\u3044\u308b\u3053\u3068\u3067\uff0c\u3088\u308a\u8a73\u7d30\u306b\u76ee\u7684\u90e8\u4f4d\u3092\u89b3\u5bdf\u3059\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u3063\u3066\u3044\u308b\uff0e<\/p>\n\n\n\n<p>*<strong>Erastin<\/strong>\uff1a\u30d5\u30a7\u30ed\u30c8\u30fc\u30b7\u30b9\u8a98\u5c0e\u5264\uff0e\u30a8\u30e9\u30b9\u30c6\u30a3\u30f3\u306f\uff0cHRAS\uff0cKRAS\u306a\u3069RAS\u3092\u6709\u3059\u308b\u816b\u760d\u7d30\u80de\u306b\u9078\u629e\u7684\u306b\u4f5c\u7528\u3059\u308b\u85ac\u5264\u3067\u3042\u308b\uff0e\u30a8\u30e9\u30b9\u30c6\u30a3\u30f3\u306f\u9244\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u751f\u6210\u3057\uff0c\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u306e\u96fb\u4f4d\u4f9d\u5b58\u6027\u30a2\u30cb\u30aa\u30f3\u30c1\u30e3\u30cd\u30eb(VDAC2\/VDAC3)\u306b\u7d50\u5408\uff0c\u3053\u308c\u3089\u3092\u963b\u5bb3\u3057\uff0c\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u5185\u3078\u306e\u30ab\u30c1\u30aa\u30f3\u6d41\u5165\u3092\u5f15\u304d\u8d77\u3053\u3057\uff0c\u9178\u5316\u7684\u7d30\u80de\u6b7b\u3092\u751f\u3058\u3055\u305b\u308b\u9178\u5316\u7684\u5206\u5b50\u3092\u653e\u51fa\u3055\u305b\u308b\u3053\u3068\u3067\uff0c\u816b\u760d\u7d30\u80de\u306b\u975e\u30a2\u30dd\u30c8\u30fc\u30b7\u30b9\u7684\u306a\u7d30\u80de\u6b7b\uff0c\u30d5\u30a7\u30ed\u30c8\u30fc\u30b7\u30b9\u3092\u8a98\u5c0e\u3059\u308b\uff0e\u5225\u540d<strong>2-[1-[4-[2-(4-<\/strong><strong>\u30af\u30ed\u30ed\u30d5\u30a7\u30ce\u30ad\u30b7<\/strong><strong>)<\/strong><strong>\u30a2\u30bb\u30c1\u30eb<\/strong><strong>]-1-<\/strong><strong>\u30d4\u30da\u30e9\u30b8\u30cb\u30eb]\u30a8\u30c1\u30eb]<\/strong><strong>-3-(2-<\/strong><strong>\u30a8\u30c8\u30ad\u30b7\u30d5\u30a7\u30cb\u30eb)<\/strong><strong>-4<\/strong><strong>(<\/strong><strong>3H<\/strong><strong>)<\/strong><strong>&#8211;<\/strong><strong>\u30ad\u30ca\u30be\u30ea\u30ce\u30f3<\/strong>\uff0c\u5316\u5b66\u5f0f\uff1aC<sub>30<\/sub>H<sub>31<\/sub>ClN<sub>4<\/sub>O<sub>4,&nbsp;<\/sub>MW 547.04.<\/p>\n\n\n\n<p>*<strong>Ferrostatin-1<\/strong>: 3-Amino-4-[cyclohexyl amino]benzoic acid ethyl ester, C<sub>15<\/sub>H<sub>22<\/sub>N<sub>2<\/sub>O<sub>2,&nbsp;<\/sub>MW 262.353<\/p>\n\n\n\n<p>*<strong>RSL3<\/strong>: Ras-specific lethal compound 3\uff0eGPx4\u306e\u30bb\u30ec\u30ce\u30b7\u30b9\u30c6\u30a4\u30f3\u6d3b\u6027\u90e8\u4f4d\u306b\u76f4\u63a5\u7d50\u5408\u3057\u9175\u7d20\u6d3b\u6027\u3092\u963b\u5bb3\u3059\u308b\u4f5c\u7528\u3092\u6709\u3059\u308b\uff0eCAS# 1219810-16-8, \u5316\u5b66\u5f0f\uff1aC<sub>23<\/sub>H<sub>21<\/sub>ClN<sub>2<\/sub>O<sub>5<\/sub>\uff0cMW 440.9.<\/p>\n\n\n\n<p>*<strong>TDQ<\/strong>: 4,9-dibromo-6,7-bis(4-hexylphenyl)-[1,2,5]thiadiazolo[3,4-g]quinoxaline<\/p>\n\n\n\n<p>*<strong>BDT<\/strong>: (4,8-didodecylbenzo[1,2-b:4,5-b\u2032]dithiophene-2,6-diyl)bis(trimethylstannane)<\/p>\n\n\n\n<p>*<strong>CPDT-Br<\/strong>: 2,6-dibromo-4,4-bis(6-bromohexyl)-4Hcyclopenta[2,1-b:3,4-b\u2032]dithiophene<\/p>\n\n\n\n<p>*<strong>PEG<\/strong>: polyethylene glycol<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u4e00\u793e\uff09\u65e5\u672c\u30cf\u30a4\u30d1\u30fc\u30b5\u30fc\u30df\u30a2\u5b66\u4f1a\u30cb\u30e5\u30fc\u30b9No.128\u3010\u5b66\u8853\u5831\u544a56\u3011 \u6700\u8fd1\u306e\u8a71\u984c56 \u8fd1\u8d64\u5916\u7ddaII\u3092\u7528\u3044\u305f\u5149\u6e29\u71b1\u30d5\u30a7\u30ed\u30c6\u30e9\u30d4\u30fc\u306e\u305f\u3081\u306e\u53ef\u5909\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u534a\u96fb\u5c0e\u6027\u30dd\u30ea\u30de\u30fc\u30ca\u30ce\u30b6\u30a4\u30e0 \u8fd1\u85e4\u3000\u9686\uff08\u5bcc\u5c71\u5927\u5b66\uff09 \u5149\u6e29\u71b1\u7642\u6cd5(Photo [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"vkexunit_cta_each_option":"","footnotes":""},"categories":[5],"tags":[],"class_list":["post-514","post","type-post","status-publish","format-standard","hentry","category-report"],"_links":{"self":[{"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/posts\/514","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/comments?post=514"}],"version-history":[{"count":1,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/posts\/514\/revisions"}],"predecessor-version":[{"id":515,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/posts\/514\/revisions\/515"}],"wp:attachment":[{"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/media?parent=514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/categories?post=514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/tags?post=514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}